Mingming Zhao, Ph.D.
Affiliations: | 2003 | Stony Brook University, Stony Brook, NY, United States |
Area:
Molecular Biology, Cell Biology, Biochemistry, OncologyGoogle:
"Mingming Zhao"Mean distance: 35622
Parents
Sign in to add mentorLinda Van Aelst | grad student | 2003 | SUNY Stony Brook | |
(Functional studies of p62(dok) in PDGFR signaling and p210(bcr-abl)-induced transformation.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Zhao M, Janas JA, Niki M, et al. (2006) Dok-1 independently attenuates Ras/mitogen-activated protein kinase and Src/c-myc pathways to inhibit platelet-derived growth factor-induced mitogenesis. Molecular and Cellular Biology. 26: 2479-89 |
Niki M, Di Cristofano A, Zhao M, et al. (2004) Role of Dok-1 and Dok-2 in leukemia suppression. The Journal of Experimental Medicine. 200: 1689-95 |
Niki M, Di Cristofano A, Zhao M, et al. (2004) Critical Role of Dok-1 and Dok-2 in Leukemia Suppression. Blood. 104: 2951-2951 |
Zhu JJ, Qin Y, Zhao M, et al. (2002) Ras and Rap control AMPA receptor trafficking during synaptic plasticity. Cell. 110: 443-55 |
Di Cristofano A, Niki M, Zhao M, et al. (2001) p62(dok), a negative regulator of Ras and mitogen-activated protein kinase (MAPK) activity, opposes leukemogenesis by p210(bcr-abl). The Journal of Experimental Medicine. 194: 275-84 |
Zhao M, Schmitz AA, Qin Y, et al. (2001) Phosphoinositide 3-kinase-dependent membrane recruitment of p62(dok) is essential for its negative effect on mitogen-activated protein (MAP) kinase activation. The Journal of Experimental Medicine. 194: 265-74 |